|
1
|
JCS Joint Working Group: Guidelines for
the diagnosis, treatment and prevention of pulmonary
thromboembolism and deep vein thrombosis (JCS 2009). Circ J, 2017.
(In Japanese).
|
|
2
|
Endo M, Tanaka Y, Sato Y, Sato Y, Ohno S
and Yoshida K: Asymptomatic pulmonary thromboembolism diagnosed
based on prolonged fever after gastric cancer surgery: A case
report with literature review. Int J Surg Case Rep.
92(106836)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Suetsugu T, Tanaka Y, Sato Y, Takaha R,
Fukada M, Yasufuku I, Okumura N, Matsuhashi N, Takahashi T and
Yoshida K: Gastric cancer receiving robotic surgery with
postoperative pulmonary thromboembolism: A case report with
literature review. Ann Vasc Surg. 8(1133)2021.
|
|
4
|
Sharma R and Rakshit B: Spatial and
temporal patterns of colorectal cancer in Asia, 1990-2019. Int J
Clin Oncol. 28:255–267. 2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hashiguchi Y, Muro K, Saito Y, Ito Y,
Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M,
et al: Japanese society for cancer of the colon and rectum (JSCCR)
guidelines 2019 for the treatment of colorectal cancer. Int J Clin
Oncol. 25:1–42. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Alastair J, Jason W, Murthy R, Lloyd R,
Tanabe Y and Prabhakar R: Imaging of acute pulmonary embolism: An
update. Cardiovasc Diagn Ther. 8:225–243. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Brierley JD, Gospodarowicz MK and
Wittekind C (eds): TNM Classification of Malignant Tumours. 8th
edition. Wiley-Blackwell, Hoboken, NJ, 2016.
|
|
8
|
U.S. Department of Health and Human
Services: Common Terminology Criteria for Adverse Events (CTCAE)
version 5.0. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf.
Accessed July 31, 2024.
|
|
9
|
Warren S and Eberhard TP: Mesenteric
venous thrombosis. Surg Gynecol Obstet. 61:102–121. 1935.
|
|
10
|
Hashizume Y, Nomura T, Suzuki S and Kondo
M: Superior mesenteric vein thrombosis treated with edoxaban. J Gen
Fam Med. 18:169–170. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Kumar S, Sarr MG and Kamath PS: Mesenteric
venous thrombosis. N Engl J Med. 345:1683–1688. 2001.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Matsumiya M, Koizumi M, Kasahara N, Endo
K, Sasanuma H, Sakuma Y, Horie H, Hosoya Y, Kitayama J and Sata N:
Intestinal resection for delayed bowel stenosis after subacute
superior mesenteric venous thrombosis: A case report. Jpn J
Gastroenterological Surg. 54:538–547. 2021.
|
|
13
|
Heit JA, Silverstein MD, Mohr DN,
Petterson TM, O'Fallon WM and Melton LJ III: Risk factors for deep
vein thrombosis and pulmonary embolism: A population-based
case-control study. Arch Intern Med. 160:809–815. 2000.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ohashi Y, Ikeda M, Kunitoh H, Sasaki M,
Okusaka T, Mukai H, Fujiwara K, Nakamura M, Oba MS, Kimura T, et
al: One-year incidence of venous thromboembolism, bleeding, and
death in patients with solid tumors newly initiating cancer
treatment: Results from the Cancer-VTE Registry. Thromb Res.
213:203–213. 2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Schmoll HJ, Cartwright T, Tabernero J,
Nowacki AF, Figer A, Maroun J, Price T, Lim R, Cutsem EV, Oark YS,
et al: Phase III trial of capecitabine plus oxaliplatin as adjuvant
therapy for stage III colon cancer: A planned safety analysis in
1,864 patients. J Clin Oncol. 25:102–109. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Lim KH, Jang J, Yoon HY and Park J: Acute
superior mesenteric vein thrombosis associated with abdominal
trauma: A rare case report and literature review. Med (Baltim).
96(e8863)2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Warshauer DM, Lee JK, Mauro MA and White
GC II: Superior mesenteric vein thrombosis with radiologically
occult cause: A retrospective study of 43 cases. AJR Am J
Roentgenol. 177:837–841. 2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Acosta S and Salim S: Management of acute
mesenteric venous thrombosis: A systematic review of contemporary
studies. Scand J Surg. 110:123–129. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Morasch MD, Ebaugh JL, Chiou AC, Matsumura
JS, Pearce WH and Yao JS: Mesenteric venous thrombosis: A changing
clinical entity. J Vasc Surg. 34:680–684. 2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Khorana AA, Kuderer NM, McCrae K,
Milentijevic D, Germain G, Laliberté F, MacKnight SD, Lefebvre P,
Lyman GH and Streiff MB: Cancer associated thrombosis and mortality
in patients with cancer stratified by Khorana score risk levels.
Cancer Med. 9:8062–8073. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Key NS, Khorana AA, Kuderer NM, Bohlke K,
Lee AY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW, et
al: Venous thromboembolism prophylaxis and treatment in patients
with cancer: ASCO clinical practice guideline update. J Clin Oncol.
38:496–520. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tanaka Y, Yamada A, Hirata S, Tanaka H,
Sakuratani T, Matsuhashi N, Yamaguchi K, Shimokawa T and Yoshida K:
Efficacy and safety of enoxaparin for prophylaxis of postoperative
venous thromboembolism after esophagectomy: A single-center
prospective randomized controlled phase II study. Anticancer Res.
39:2615–2625. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Raskob GE, van Es N, Verhamme P, Carrier
M, Nisio MD, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF,
et al: Edoxaban for the treatment of cancer-associated venous
thromboembolism. N Engl J Med. 378:615–624. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Mandalà M, Falanga A and Roila F: ESMO
guidelines working group. Management of venous thromboembolism
(VTE) in cancer patients: ESMO clinical practice guidelines. Ann
Oncol. 22:vi85–vi92. 2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhou Y, Ingelman SM and Lauschke VM:
Worldwide distribution of cytochrome P450 alleles: A meta-analysis
of population-scale sequencing projects. Clin Pharmacol Ther.
102:688–700. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Bellesoeur A, Thomas-Schoemann A, Allard
M, Smadja D, Vidal M, Alexandre J, Goldwasser F and Blanchet B:
Pharmacokinetic variability of anticoagulants in patients with
cancer-associated thrombosis: Clinical consequences. Crit Rev Oncol
Hematol. 129:102–112. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mar PL, Gopinathannair R, Gengler BE,
Chung MK, Perez A, Dukes J, Ezekowitz MD, Lakkireddy D, Lip GYH,
Miletello M, et al: Drug interactions affecting oral anticoagulant
use. Circ-Arrhythmia Electrophysiol. 15(e007956)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Leentjens J, Middeldrop S and Jung C: A
short review of ciraparantag in perspective of the currently
available anticoagulant reversal agents. J Drug Discov Today.
27(103332)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Escolar G, Diaz-Ricart M and
Arellano-Rodrigo E: Andexanet alfa: A recombinant mimetic of human
factor Xa for the reversal of anticoagulant therapies. Drugs Today
(Barc). 53:271–282. 2017.PubMed/NCBI View Article : Google Scholar
|
